SpringWorks Therapeutics Inc (SWTX) — Cash Flow Reinvestment Rate

Latest as of December 2020: 14.79x

SpringWorks Therapeutics Inc (SWTX) has a Cash Flow Reinvestment Rate of 14.79x as of December 2020, reinvesting $222.84 Million (capex $54.00K plus investments $-222.78 Million) from operating cash flow of $15.07 Million. See cash generation quality of SpringWorks Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

14.79x
(Capex + Investments) / Operating CF

Total Reinvested

$222.84 Million
Capex + Investments

Operating Cash Flow

$15.07 Million
USD

Capital Expenditures

$54.00K
USD

SpringWorks Therapeutics Inc Cash Flow Reinvestment Rate (2000–2010)

Historical reinvestment intensity for SpringWorks Therapeutics Inc across 9 annual periods. For the full cash flow conversion analysis, see SpringWorks Therapeutics Inc operating cash flow efficiency.

Annual Cash Flow Reinvestment Rate for SpringWorks Therapeutics Inc (2000–2010)

Year-by-year capital reinvestment analysis for SpringWorks Therapeutics Inc. See financial flexibility index of SpringWorks Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2010 0.34x $1.89 Million $5.61 Million $1.89 Million ▲ +2.1%
2009 0.33x $1.73 Million $5.23 Million $1.73 Million ▲ +274.2%
2008 0.09x $626.00K $7.10 Million $626.00K ▼ -29.3%
2007 0.12x $710.00K $5.70 Million $710.00K ▼ -92.2%
2006 1.59x $1.19 Million $748.00K $1.19 Million ▲ +733.4%
2005 0.19x $766.00K $4.01 Million $766.00K ▲ +91.7%
2004 0.10x $382.00K $3.83 Million $382.00K
2001 0.00x $0.00 $13.79 Million $0.00
2000 0.00x $0.00 $1.59 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow